We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.3B
AUM Growth
+$50.2M
Cap. Flow
-$180M
Cap. Flow %
-4.19%
Top 10 Hldgs %
8.21%
Holding
2,738
New
923
Increased
478
Reduced
355
Closed
498

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$20.1M
2
AXAC
AXIOS Sustainable Growth Acquisition Corporation
AXAC
+$11M
3
CNGL
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
+$9.93M
4
SAGA
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
+$9.76M
5
NUBIU
Nubia Brand International Corp. Unit
NUBIU
+$9.67M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$103M
2
PFE icon
Pfizer
PFE
+$63M
3
CRM icon
Salesforce
CRM
+$40.7M
4
XLNX
Xilinx Inc
XLNX
+$32.9M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26M

Sector Composition

Rank Sector Weight
1 Financials 13.47%
2 Healthcare 7.77%
3 Technology 7.7%
4 Consumer Discretionary 4.85%
5 Energy 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWPPW
2151
DELISTED
Perella Weinberg Partners Warrant
PWPPW
$42K ﹤0.01%
20,719
-6,906
-25% -$17.7K
BDTX icon
2152
Black Diamond Therapeutics
BDTX
$110M
$41K ﹤0.01%
14,931
– –
DBGIW
2153
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$41K ﹤0.01%
215
– –
GRI
2154
GRI Bio
GRI
$2.74M
– –
0
– –
MNTSW icon
2155
Momentus Inc Warrant
MNTSW
$47
$40K ﹤0.01%
12,597
– –
IGTAR
2156
DELISTED
Inception Growth Acquisition Limited Rights
IGTAR
$40K ﹤0.01%
+250,000
New +$43.5K
MPACR
2157
DELISTED
Model Performance Acquisition Corp. Right
MPACR
$40K ﹤0.01%
225,000
– –
MAAQR
2158
DELISTED
Mana Capital Acquisition Corp. Rights
MAAQR
$40K ﹤0.01%
+200,000
New +$51.8K
IRD
2159
Opus Genetics
IRD
$307M
$39K ﹤0.01%
11,901
– –
BIOR
2160
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$38K ﹤0.01%
132
+10
+8% +$3.79K
KPLTW
2161
DELISTED
Katapult Holdings Warrant
KPLTW
$37K ﹤0.01%
15,398
– –
RGLS
2162
DELISTED
Regulus Therapeutics
RGLS
$37K ﹤0.01%
12,406
– –
ASXC
2163
DELISTED
Asensus Surgical, Inc.
ASXC
$37K ﹤0.01%
+58,620
New +$45.2K
CZOO
2164
DELISTED
Cazoo Group Ltd
CZOO
$37K ﹤0.01%
+7
New +$53.3K
CRIS icon
2165
Curis
CRIS
$8.59M
$36K ﹤0.01%
+38
New +$48.5K
MUX icon
2166
McEwen Inc
MUX
$1.12B
$36K ﹤0.01%
4,279
+69
+2% +$595
PGEN icon
2167
Precigen
PGEN
$2.47B
$36K ﹤0.01%
+17,046
New +$41.5K
TCRT icon
2168
Alaunos Therapeutics
TCRT
$4.86M
$36K ﹤0.01%
+367
New +$47.1K
KA
2169
DELISTED
Kineta, Inc. Common Stock
KA
$36K ﹤0.01%
3,398
– –
CTMX icon
2170
CytomX Therapeutics
CTMX
$734M
$35K ﹤0.01%
+13,101
New +$50.3K
TMCWW
2171
TMC The Metals Company Warrants
TMCWW
$428K
$35K ﹤0.01%
13,673
-120,410
-90% -$40K
BRACR
2172
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$35K ﹤0.01%
+214,500
New +$40.4K
DTIL icon
2173
Precision BioSciences
DTIL
$205M
$34K ﹤0.01%
+373
New +$50.7K
KOPN icon
2174
Kopin
KOPN
$756M
$34K ﹤0.01%
+13,335
New +$38.4K
CYTO
2175
DELISTED
Altamira Therapeutics Ltd
CYTO
$34K ﹤0.01%
77
– –
85 86
87
88 89

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q1 2022 Portfolio in Review

As of Q1 2022, Boothbay Fund Management held 2,738 positions worth $4.3B, up 1.2% from $4.25B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Boothbay Fund Management withdrew a net $180M in Q1 2022, closing 498 positions and reducing 355 holdings. Its most notable exit was Xilinx Inc, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in AXIOS Sustainable Growth Acquisition Corporation worth $11M.

  • Boothbay Fund Management's largest Q1 2022 buy was AXIOS Sustainable Growth Acquisition Corporation: 1,100,000 shares worth $11M.
  • Boothbay Fund Management added most to iShares MBS ETF in Q1 2022, an estimated $20.1M increase.
  • Boothbay Fund Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $103M.
  • Boothbay Fund Management fully exited Xilinx Inc in Q1 2022, selling an estimated $32.9M.
  • Boothbay Fund Management's ten largest holdings make up 8.2% of its $4.3B portfolio in Q1 2022.
  • Boothbay Fund Management opened 923 new positions and closed 498 in Q1 2022.
  • Boothbay Fund Management's portfolio value rose 1.2% quarter-over-quarter to $4.3B.

Based on Boothbay Fund Management's 13F filing for Q1 2022, filed 16 May 2022.